Regulation of cardiac fibroblast cellular function by leukemia inhibitory factor

被引:48
作者
Wang, F
Trial, J
Diwan, A
Gao, F
Birdsall, HH
Entman, ML
Hornsby, PJ
Sivasubramaniam, N
Mann, DL
机构
[1] Winters Ctr Heart Failure Res, Houston, TX 77030 USA
[2] Baylor Coll Med, Houston VAMC, Huffington Ctr Aging, Houston, TX 77030 USA
[3] Baylor Coll Med, Houston VAMC, Dept Otorhinolaryngol, Houston, TX 77030 USA
[4] Baylor Coll Med, Houston VAMC, Dept Med, Houston, TX 77030 USA
[5] Methodist Hosp, DeBakey Heart Ctr, Program Cardiovasc Sci, Houston, TX 77030 USA
关键词
cytokine; leukemia inhibitory factor; cardiac fibroblast; proliferation; differentiation; collagen content; MMP activity;
D O I
10.1006/jmcc.2002.2059
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Previous studies have shown that leukemia inhibitory factor (LIF) provokes hypertrophic and cytoprotective effects in cardiac myocytes. However, the effects of LIF in cardiac fibroblasts are not known. Given that the cardiac fibroblast is the most abundant cell type in the heart, we sought to examine the functional effects of LIF on cardiac fibroblasts in vitro. Results: Short-term LIF stimulation (24 h) had no effect on fibroblast proliferation and/or cell differentiation. However. longer-term LIT stimulation (48-72 h) increased fibroblast proliferation, and significantly inhibited cardiac fibroblast differentiation into myofibroblasts. Moreover, 72 It of LIF stimulation significantly reduced collagen content in cardiac fibroblasts cultures, as well as decreased MMP activity in fibroblast culture supernatants. Conclusion: The results of this study suggest that LIF stimulation down-regulates several key components of the remodeling process, including collagen content and matrix metalloproteinase (MMP) activation, and thus suggest that LIF may play an important autocrine/paracrine role in preventing excessive extracellular matrix remodeling following acute myocardial injury. (C) 2002 Published by Elsevier Science Ltd.
引用
收藏
页码:1309 / 1316
页数:8
相关论文
共 50 条
  • [41] Macrophage-derived tumor necrosis factor and tumor-derived of leukemia inhibitory factor and interleukin-6: Possible cellular mechanisms of cancer cachexia
    Billingsley, KG
    Fraker, DL
    Strassmann, G
    Loeser, C
    Fliot, HM
    Alexander, HR
    ANNALS OF SURGICAL ONCOLOGY, 1996, 3 (01) : 29 - 35
  • [42] Leukemia inhibitory factor signaling in Xenopus embryo: Insights from gain of function analysis and dominant negative mutant of the receptor
    Jalvy, Sandra
    Veschambre, Philippe
    Fedou, Sandrine
    Rezvani, Hamid Reza
    Theze, Nadine
    Thiebaud, Pierre
    DEVELOPMENTAL BIOLOGY, 2019, 447 (02) : 200 - 213
  • [43] Leukemia inhibitory factor induces endothelial differentiation in cardiac Sca-1+stem cells
    Tomomi, Mohri
    Yasushi, Fujio
    Makiko, Maeda
    Takashi, Ito
    Tomo-hiko, Iwakura
    Yuichi, Oshima
    Yoriko, Uozumi
    Yasuhiro, Yamamoto
    Junichi, Azuma
    ACTA PHARMACOLOGICA SINICA, 2006, 27 : 183 - 183
  • [44] Differential adaptation of growth and differentiation factor 8/myostatin, fibroblast growth factor 6 and leukemia inhibitory factor in overloaded, regenerating and denervated rat muscles
    Sakuma, K
    Watanabe, K
    Sano, M
    Uramoto, I
    Totsuka, T
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2000, 1497 (01): : 77 - 88
  • [45] Therapeutic regulation of cardiac fibroblast function: targeting stress-activated protein kinase pathways
    Turner, Neil A.
    FUTURE CARDIOLOGY, 2011, 7 (05) : 673 - 691
  • [46] Activating transcription factor 3 promotes embryo attachment via up-regulation of leukemia inhibitory factor in vitro
    Cheng, Xi
    Liu, Jingyu
    Shan, Huizhi
    Sun, Lihua
    Huang, Chenyang
    Yan, Qiang
    Jiang, Ruiwei
    Ding, Lijun
    Jiang, Yue
    Zhou, Jianjun
    Yan, Guijun
    Sun, Haixiang
    REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY, 2017, 15
  • [47] Leukemia inhibitory factor functions as a growth factor in pancreas carcinoma cells: Involvement of regulation of LIF and its receptor expression
    Kamohara, Hidenobu
    Ogawa, Michio
    Ishiko, Takatoshi
    Sakamoto, Kiyoshi
    Baba, Hideo
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2007, 30 (04) : 977 - 983
  • [48] Leukemia inhibitory factor is dysregulated in ankylosing spondylitis and contributes to bone formation
    Kong, Weiping
    Tang, Yulong
    Tang, Kunhai
    Yan, Zeran
    Liu, Ting
    Tao, Qingwen
    Wang, Jiucun
    Liu, Jing
    Yan, Xiaoping
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2022, 25 (05) : 592 - 600
  • [49] ATP induces leukemia inhibitory factor mRNA in cultured rat astrocytes
    Yamakuni, H
    Kawaguchi, N
    Ohtani, Y
    Nakamura, J
    Katayama, T
    Nakagawa, T
    Minami, M
    Satoh, M
    JOURNAL OF NEUROIMMUNOLOGY, 2002, 129 (1-2) : 43 - 50
  • [50] Leukemia inhibitory factor, glycodelin, and HOXA-10 in gestational diabetes
    Aydin, Y.
    Uludag, S.
    Atis, A.
    Ilvan, S.
    CLINICAL AND EXPERIMENTAL OBSTETRICS & GYNECOLOGY, 2019, 46 (04) : 539 - 541